Skip to content

Clinical trials

Completed Diabetic Neuropathies trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Neuropathies Status: Completed Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20051
20062
20071
20103
20111
20122
20141
20191
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
McMaster University2
Takeda2
AbbVie (prior sponsor, Abbott)1
Chromaderm, Inc.1
LMC Diabetes & Endocrinology Ltd.1
Ottawa Hospital Research Institute1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Samuel Lunenfeld Research Institute, Mount Sinai Hospital1
Sumitomo Pharma Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Neuropathies18
Diabetes Mellitus6
Pain5
Diabetes Mellitus, Type 14
Diabetes Mellitus, Type 24
Chronic Pain1
Diabetes Complications1
Diabetic Foot1
Foot Deformities1
Insulin Resistance1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.